GlaxoSmithKline (GSK) Q3 EPS Falls to 22.6p; Revs Lower Y/Y

GlaxoSmithKline (NYSE: GSK) reported Q3 EPS of 22.6 pence, versus 27.2 pence reported last year. Revenue for the quarter came in at GBP6.53 billion, versus GBP7.1 billion reported last year.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Optimum Communications gets NYSE non-compliance notice over stock price